A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial.
Maureen M AchebeJohn GlaspyPhilip A KalraMichael AuerbachLars L ThomsenSunil BhandariPublished in: American journal of hematology (2020)